Screening and surveillance of colorectal cancer

Charles Kahi, Douglas Rex

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Although colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States, it is preventable. Screening modalities include fecal occult blood testing, flexible sigmoidoscopy, double-contrast barium enema, and colonoscopy. Colonoscopy allows effective detection and removal of precursor adenomatous polyps and is the dominant CRC screening modality. Emerging technologies include CT and MR colonography and fecal DNA tests. Effective and cost-effective surveillance after polypectomy and curative CRC resection requires balancing the protective effect of polypectomy while maximizing intervals between examinations; thus, estimation of the risk of recurrence determines the intensity of surveillance for individual patients.

Original languageEnglish
Pages (from-to)533-547
Number of pages15
JournalGastrointestinal Endoscopy Clinics of North America
Volume15
Issue number3
DOIs
StatePublished - Jul 2005

Fingerprint

Colorectal Neoplasms
Colonoscopy
Computed Tomographic Colonography
Adenomatous Polyps
Sigmoidoscopy
Occult Blood
Early Detection of Cancer
Cause of Death
Technology
Costs and Cost Analysis
Recurrence
DNA
Neoplasms
Barium Enema

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology

Cite this

Screening and surveillance of colorectal cancer. / Kahi, Charles; Rex, Douglas.

In: Gastrointestinal Endoscopy Clinics of North America, Vol. 15, No. 3, 07.2005, p. 533-547.

Research output: Contribution to journalArticle

@article{47565103fbab4144a0eba149a3ed36cb,
title = "Screening and surveillance of colorectal cancer",
abstract = "Although colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States, it is preventable. Screening modalities include fecal occult blood testing, flexible sigmoidoscopy, double-contrast barium enema, and colonoscopy. Colonoscopy allows effective detection and removal of precursor adenomatous polyps and is the dominant CRC screening modality. Emerging technologies include CT and MR colonography and fecal DNA tests. Effective and cost-effective surveillance after polypectomy and curative CRC resection requires balancing the protective effect of polypectomy while maximizing intervals between examinations; thus, estimation of the risk of recurrence determines the intensity of surveillance for individual patients.",
author = "Charles Kahi and Douglas Rex",
year = "2005",
month = "7",
doi = "10.1016/j.giec.2005.04.005",
language = "English",
volume = "15",
pages = "533--547",
journal = "Gastrointestinal Endoscopy Clinics of North America",
issn = "1052-5157",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Screening and surveillance of colorectal cancer

AU - Kahi, Charles

AU - Rex, Douglas

PY - 2005/7

Y1 - 2005/7

N2 - Although colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States, it is preventable. Screening modalities include fecal occult blood testing, flexible sigmoidoscopy, double-contrast barium enema, and colonoscopy. Colonoscopy allows effective detection and removal of precursor adenomatous polyps and is the dominant CRC screening modality. Emerging technologies include CT and MR colonography and fecal DNA tests. Effective and cost-effective surveillance after polypectomy and curative CRC resection requires balancing the protective effect of polypectomy while maximizing intervals between examinations; thus, estimation of the risk of recurrence determines the intensity of surveillance for individual patients.

AB - Although colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States, it is preventable. Screening modalities include fecal occult blood testing, flexible sigmoidoscopy, double-contrast barium enema, and colonoscopy. Colonoscopy allows effective detection and removal of precursor adenomatous polyps and is the dominant CRC screening modality. Emerging technologies include CT and MR colonography and fecal DNA tests. Effective and cost-effective surveillance after polypectomy and curative CRC resection requires balancing the protective effect of polypectomy while maximizing intervals between examinations; thus, estimation of the risk of recurrence determines the intensity of surveillance for individual patients.

UR - http://www.scopus.com/inward/record.url?scp=21244497695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21244497695&partnerID=8YFLogxK

U2 - 10.1016/j.giec.2005.04.005

DO - 10.1016/j.giec.2005.04.005

M3 - Article

C2 - 15990056

AN - SCOPUS:21244497695

VL - 15

SP - 533

EP - 547

JO - Gastrointestinal Endoscopy Clinics of North America

JF - Gastrointestinal Endoscopy Clinics of North America

SN - 1052-5157

IS - 3

ER -